Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis-Reference-Cited by-同舟云学术

Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis

Published:2014-01 Issue:1 Volume:1840 Page:586-594
ISSN:0304-4165
Container-title:Biochimica et Biophysica Acta (BBA) - General Subjects
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - General Subjects

Author:

Caretti Anna,Bragonzi Alessandra,Facchini Marcella,De Fino Ida,Riva Camilla,Gasco Paolo,Musicanti Claudia,Casas Josefina,Fabriàs Gemma,Ghidoni Riccardo,Signorelli Paola

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference52 articles.

1. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling;Chalfant;J. Cell Sci.,2005

2. Bioactive sphingolipids in the modulation of the inflammatory response;El Alwani;Pharmacol. Ther.,2006

3. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin;Miyake;Biochem. Biophys. Res. Commun.,1995

4. TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced “acidic” sphingomyelin breakdown;Schutze;Cell,1992

5. Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells;Sawai;J. Biol. Chem.,1995

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The shifting lipidomic landscape of blood monocytes and neutrophils during pneumonia;JCI Insight;2024-02-22

2. Sphingosine kills intracellular Pseudomonas aeruginosa and Staphylococcus aureus;Pathogens and Disease;2024

3. Reduced Sphingosine in Cystic Fibrosis Increases Susceptibility to Mycobacterium abscessus Infections;International Journal of Molecular Sciences;2023-09-12

4. The therapeutic potential of sphingolipids for cardiovascular diseases;Frontiers in Cardiovascular Medicine;2023-08-07

5. Cross‐talk between CFTR and sphingolipids in cystic fibrosis;FEBS Open Bio;2023-06-22